Skin Cancer

Malignant Melanoma

Cutaneous malignant melanoma is the most aggressive form of skin cancer and a significant cause of death worldwide. Sweden, with a population of 9,6 million, has one of the highest incidence rates of melanoma. During the past 10 years, the incidence of melanoma in Sweden has increased by almost 6 percent annually. In 2012, there were 3343 new cases of invasive melanoma, and 2620 new cases of in situ melanoma reported in Sweden.

Over 150.000 excisions of melanocytic lesion are performed on approximately 100.000 individuals each year in order to identify the number of melanomas above. The cost for these excisions exceed 30 million euros annually. The total cost for skin cancer care in Sweden is estimated to 177,6 million euros and cutaneous malignant melanoma accounts for more than 50 % of these figures.

Nearly 85 percent of all patients with melanoma are cured thanks to early detection and control of the disease. Today, about 35.000 individuals with the diagnosis of melanoma are living in Sweden.

Our Solution – Dermicus Mole

Early detection of melanoma is crucial for disease prognosis. Melanoma specialist skills should therefore be in reach for the general practitioner at patient’s first consultation. Dermicus is a Teledermatoscopy system and works as a non-invasive clinical decision support tool to healthcare professionals.

The system includes a mobile phone, an application, a customized dermatoscopy and a server platform. The system can be described as a query referral and gives the receiver – thanks to the digital images – a more complete basis for guidance on the clinical management of patients with Melanoma.

The General Practitioner (GP) uses mobile teledermatoscopy to send clinical data and pictures through a mobile application to the platform. The melanoma specialists analyse the data on the platform and produce a standardised report. Via the secured platform the GP gets access to the diagnosis and the clinical support regarding how to handle the pigmented skin lesion.

Structured assessments and reports

The platform offers a standardised Digital Dermatoscopy Diagnose Report based on Revised Pattern Analysis including recommendation on diagnostic excision by the GP or external surgeon / plastic surgeon depending on size and location of the lesion. The assessment is in a consensus diagnosis setting involving two or more melanoma specialists to yield optimal diagnostic accuracy.

Supporting multidisciplinary teams

The platform offers a teledermatoscopic digital service that provides all specialists (GP, dermatologist, surgeon and pathologist) with the collected data throughout the whole melanoma referral process.

Patient data security

The CE-labelled platform Dermicus complies with the requirements for GDPR, encryption, authentication, secure login and storage of data.




Melanoma specialist skills transfer through digital services (teledermatoscopy) to the primary care will provide a better selection of suspicious lesions, thereby reducing referrals of benign skin tumours. Melanoma specialist assessments at patients first visit results in fewer unnecessary excisions, associated reduced load on pathology laboratories with improved pathology report response times and decreased health care spending. Fast and accurate diagnosis of melanoma provides a high qualitative process and an improved patient experience – ultimately early diagnosis saves lives.